The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals
Open accessAbstract
CONTEXT: The risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) associated with obesity appears to be influenced by the coexistence of other metabolic abnormalities. OBJECTIVE: We examined the risk of developing CVD and DM in metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUH-NW) individuals. DESIGN AND SETTING: We analyzed prospective data of the San Antonio Heart Study, a population-based study among Mexican Americans and non-Hispanic whites (median follow-up, 7.4 y). PARTICIPANTS: Incident DM and CVD were assessed in 2814 and 3700 participants aged 25 to 64 years, respectively. MAIN MEASURES: MHO was defined as obesity (body mass index ≥ 30 kg/m(2)) with no more than one metabolic abnormality, and MUH-NW was defined as body mass index <25 kg/m(2) with two or more abnormalities. RESULTS: In logistic regression models, BMI was associated with incident DM after controlling for demographics, family history of DM, and fasting glucose (odds ratio × 1 SD, 1.7 [95% CI, 1.5-2.0]). Both MUH-NW and MHO individuals had an increased DM risk (2.5 [1.1-5.6] and 3.9 [2.0-7.4], respectively). Similarly, BMI was related to incident CVD after adjusting for demographics and Framingham risk score (1.3 [1.1-1.6]). Incident CVD was also increased in MUH-NW and MHO individuals (2.9 [1.3-6.4] and 3.9 [1.9-7.8], respectively). Results were consistent across gender and ethnic categories. CONCLUSION: The risk of developing DM and CVD is increased in MUH-NW and MHO individuals. Screening for obesity and other metabolic abnormalities should be routinely performed in clinical practice to institute appropriate preventive measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Wildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., Sullivan, L. M., & D’Agostino, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0594 · Cited by 1,062
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Klöting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schön, M. R., Kern, M., Stumvoll, M., & Blüher, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2009 · Cited by 856
Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0165 · Cited by 723
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality
Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Korenfeld, Y., Boarin, S., Korinek, J., Jensen, M. D., Parati, G., & Lopez-Jimenez, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp487 · Cited by 688
Gómez-Ambrosi, J., Silva, C., Galofré, J. C., Escalada, J., Santos, S., Millán, D., Vila, N., Ibañez, P., Gil, M. J., Valentí, V, et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.100 · Cited by 615
Ärnlöv, J., Ingelsson, E., Sundström, J., & Lind, L. (2010) · Circulation · doi:10.1161/circulationaha.109.887521 · Cited by 611
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
Hamer, M., & Stamatakis, E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3475 · Cited by 564
The “metabolically-obese,” normal-weight individual
Ruderman, N. B., Schneider, S. H., & Berchtold, P. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.8.1617 · Cited by 545
Stern, M. P., Williams, K., & Haffner, S. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00006 · Cited by 510
Self-citationDiabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype
Appleton, S. L., Seaborn, C. J., Visvanathan, R., Hill, C. L., Gill, T. K., Taylor, A. W., Adams, R. J., & on behalf of the North West Adelaide Health Study Team (2013) · Diabetes Care · doi:10.2337/dc12-1971 · Cited by 478
Ortega, F. B., Lee, D.-C., Katzmarzyk, P. T., Ruiz, J. R., Sui, X., Church, T. S., & Blair, S. N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs174 · Cited by 468
Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals
Calori, G., Lattuada, G., Piemonti, L., Garancini, M. P., Ragogna, F., Villa, M., Mannino, S., Crosignani, P., Bosi, E., Luzi, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-0665 · Cited by 346
Relationship between degree of obesity and in vivo insulin action in man
Bogardus, C., Lillioja, S., Mott, D. M., Hollenbeck, C., & Reaven, G. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.3.e286 · Cited by 344
Metabolically Healthy Obesity and Risk of Mortality
Hinnouho, G.-M., Czernichow, S., Dugravot, A., Batty, G. D., Kivimaki, M., & Singh-Manoux, A. (2013) · Diabetes Care · doi:10.2337/dc12-1654 · Cited by 317
Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?
Kuk, J. L., & Ardern, C. I. (2009) · Diabetes Care · doi:10.2337/dc09-0574 · Cited by 286
Bergeron, R., Previs, S. F., Cline, G. W., Perret, P., Russell III, R. R., Young, L. H., & Shulman, G. I. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1076 · Cited by 283
Metabolically Healthy but Obese, a Matter of Time? Findings From the Prospective Pizarra Study
Soriguer, F., Gutiérrez-Repiso, C., Rubio-Martín, E., García-Fuentes, E., Almaraz, M. C., Colomo, N., Esteva de Antonio, I., de Adana, M. S. R., Chaves, F. J., Morcillo, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4253 · Cited by 251
Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E. C., Murashima, S., Maruyama, N., Morioka, K., Nakatani, K., Yano, Y., & Adachi, Y. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2341 · Cited by 234
Xu, X. J., Gauthier, M.-S., Hess, D. T., Apovian, C. M., Cacicedo, J. M., Gokce, N., Farb, M., Valentine, R. J., & Ruderman, N. B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p022905 · Cited by 229
Are there still healthy obese patients?
Blüher, M. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328357f0a3 · Cited by 175
Metabolically healthy but obese women: effect of an energy-restricted diet
Karelis, A. D., Messier, V., Brochu, M., & Rabasa-Lhoret, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1038-4 · Cited by 165
Incident Cardiovascular Disease Events in Metabolically Benign Obese Individuals
Ogorodnikova, A. D., Kim, M., McGinn, A. P., Muntner, P., Khan, U. I., & Wildman, R. P. (2011) · Obesity · doi:10.1038/oby.2011.243 · Cited by 160
Succurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., & Sesti, G. (2008) · Obesity · doi:10.1038/oby.2008.308 · Cited by 158
Effects of a lifestyle intervention in metabolically benign and malign obesity
Kantartzis, K., Machann, J., Schick, F., Rittig, K., Machicao, F. E., Fritsche, A., Häring, H., & Stefan, N. (2010) · Diabetologia · doi:10.1007/s00125-010-2006-3 · Cited by 155
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease
St-Pierre, A., Cantin, B., Mauriège, P., Bergeron, J., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040834 · Cited by 147
Choi, K. M., Cho, H. J., Choi, H. Y., Yang, S. J., Yoo, H. J., Seo, J. A., Kim, S. G., Baik, S. H., Choi, D. S., & Kim, N. H. (2013) · Clinical Endocrinology · doi:10.1111/cen.12154 · Cited by 142
Obesity rising to alarming levels around the world
McLellan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08397-6 · Cited by 138
Hwang, L. C., Bai, C. H., Sun, C. A., & Chen, C. (2012) · PubMed · Cited by 132
Predicting Future Cardiovascular Disease
Stern, M. P., Fatehi, P., Williams, K., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1851 · Cited by 83
Self-citationKwon, B., Kim, D., Her, S., Kim, D., Jang, S.-W., Cho, E.-J., Ihm, S., Kim, H.-Y., Youn, H., Seung, K., et al. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.006 · Cited by 56
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients
Muscelli, E., Camastra, S., Gastaldelli, A., Natali, A., Masoni, A., Pecori, N., & Ferrannini, E. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800580 · Cited by 48
Cited by
The Definition and Prevalence of Obesity and Metabolic Syndrome
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_1 · Cited by 1,180
Khan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797
Enzyme‐Based Glucose Sensor: From Invasive to Wearable Device
Lee, H., Hong, Y. J., Baik, S., Hyeon, T., & Kim, D. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701150 · Cited by 778
Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis.
Eckel, N., Meidtner, K., Kalle-Uhlmann, T., Stefan, N., & Schulze, M. B. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315623884 · Cited by 405
Obesity phenotypes and their paradoxical association with cardiovascular diseases
Vecchié, A., Dallegri, F., Carbone, F., Bonaventura, A., Liberale, L., Portincasa, P., Frühbeck, G., & Montecucco, F. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.020 · Cited by 329
Metadata
- Authors
- Aung, K., Lorenzo, C., Hinojosa, M. A., & Haffner, S. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-02-01
- Volume
- 99
- Issue
- 2
- Pages
- 462-468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1972635368
- Cited by
- 266
- References
- 40
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.